Latest news
Director gifts 6,050 TG Therapeutics (TGTX) shares to 501(c)(3) - Stock TitanStock Titan · Fri, 07 Aug 2026 21:01:37 GMTTG Therapeutics (TGTX) Is Down 7.4% After Q2 Profit Drop Despite Higher 2026 Revenue Guidance – Has The Bull Case Changed? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:56:09 GMTTG Therapeutics Earnings Call Signals BRIUMVI Surge - The Globe and MailThe Globe and Mail · Thu, 06 Aug 2026 01:06:00 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics (NASDAQ: TGTX) grows 2026 revenue to $445 million - Stock TitanStock Titan · Wed, 05 Aug 2026 21:01:51 GMTEmpowered Funds LLC Increases Stake in TG Therapeutics, Inc. $TGTX - MarketBeatMarketBeat · Wed, 05 Aug 2026 08:36:17 GMTTG Therapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 12:30:00 GMTTG Therapeutics (TGTX) Is Down 15.9% After Q2 Miss But Raised 2026 Outlook - What's Changed - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 04:39:00 GMT